Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma.

Magee KE, Kelsey CE, Kurzinski KL, Ho J, Mlakar LR, Feghali-Bostwick CA, Torok KS.

Arthritis Res Ther. 2013;15(6):R188.

2.

Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.

Torok KS, Kurzinski K, Kelsey C, Yabes J, Magee K, Vallejo AN, Medsger T Jr, Feghali-Bostwick CA.

Semin Arthritis Rheum. 2015 Dec;45(3):284-93. doi: 10.1016/j.semarthrit.2015.06.006. Epub 2015 Jun 17.

3.

The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population.

Kelsey CE, Torok KS.

J Am Acad Dermatol. 2013 Aug;69(2):214-20. doi: 10.1016/j.jaad.2013.02.007. Epub 2013 Apr 4.

4.

Histopathologic differentiation between localized and systemic scleroderma.

Torres JE, Sánchez JL.

Am J Dermatopathol. 1998 Jun;20(3):242-5.

PMID:
9650695
5.

Expression of transforming growth factor-beta and platelet-derived growth factor in linear scleroderma.

Restrepo JF, Guzmán R, Rodríguez G, Iglesias A.

Biomedica. 2003 Dec;23(4):408-15.

PMID:
14968919
6.

The production of interferon-gamma-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity.

Noguchi A, Watanabe K, Narumi S, Yamagami H, Fujiwara Y, Higuchi K, Oshitani N, Arakawa T.

J Gastroenterol. 2007 Dec;42(12):947-56. Epub 2007 Dec 25.

PMID:
18085351
7.
8.

Significantly increased CCL5/RANTES and CCR7 mRNA levels in localized scleroderma.

Gambichler T, Skrygan M, Labanski AA, Kolios AG, Altmeyer P, Kreuter A.

Regul Pept. 2011 Oct 10;170(1-3):4-6. doi: 10.1016/j.regpep.2011.05.003. Epub 2011 May 25.

PMID:
21616095
9.

[3H]Thymidine labeling of dermal endothelial cells in scleroderma.

Fleischmajer R, Perlish JS.

J Invest Dermatol. 1977 Oct;69(4):379-82.

10.
11.

Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection.

Syed Ahamed Kabeer B, Paramasivam P, Raja A.

J Infect. 2012 Jun;64(6):573-9. doi: 10.1016/j.jinf.2012.02.013. Epub 2012 Feb 27.

12.

Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.

Alsleben N, Ruhwald M, Rüssmann H, Marx FM, Wahn U, Magdorf K.

Scand J Infect Dis. 2012 Apr;44(4):256-62. doi: 10.3109/00365548.2011.632644. Epub 2011 Nov 21.

PMID:
22103555
13.

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis.

Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, Ravn P; TBNET.

Eur Respir J. 2008 Dec;32(6):1607-15. doi: 10.1183/09031936.00055508. Epub 2008 Aug 6.

14.

Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.

Wang Y, Zhao C, Zhang L, Yu W, Shen C, Wang W, Zhen Z, Zhou J.

Antiviral Res. 2014 Mar;103:51-9. doi: 10.1016/j.antiviral.2014.01.001. Epub 2014 Jan 10.

PMID:
24418572
15.

The role of local temperature and other clinical characteristics of localized scleroderma as markers of disease activity.

Garcia-Romero MT, Randhawa HK, Laxer R, Pope E.

Int J Dermatol. 2017 Jan;56(1):63-67. doi: 10.1111/ijd.13452.

PMID:
27943304
16.

The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.

Arkachaisri T, Vilaiyuk S, Li S, O'Neil KM, Pope E, Higgins GC, Punaro M, Rabinovich EC, Rosenkranz M, Kietz DA, Rosen P, Spalding SJ, Hennon TR, Torok KS, Cassidy E, Medsger TA Jr; Localized Scleroderma Clinical and Ultrasound Study Group.

J Rheumatol. 2009 Dec;36(12):2819-29. doi: 10.3899/jrheum.081284. Epub 2009 Oct 15.

17.

Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.

Kreuter A, Hyun J, Skrygan M, Sommer A, Tomi NS, Breuckmann F, Altmeyer P, Gambichler T.

Arch Dermatol Res. 2006 Nov;298(6):265-72. Epub 2006 Sep 19.

PMID:
17009056
18.

Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-β1 expression, and increases Foxp3-expressing cells in localized scleroderma.

Furuzawa-Carballeda J, Ortíz-Ávalos M, Lima G, Jurado-Santa Cruz F, Llorente L.

Clin Exp Dermatol. 2012 Aug;37(6):599-609. doi: 10.1111/j.1365-2230.2012.04385.x. Epub 2012 Jun 25.

PMID:
22731679
19.

Localized scleroderma severity index and global assessments: a pilot study of outcome instruments.

Arkachaisri T, Pino S.

J Rheumatol. 2008 Apr;35(4):650-7. Epub 2008 Mar 1. Erratum in: J Rheumatol. 2009 Sep;36(9):2136.

PMID:
18322985
20.

In vivo study of scleroderma by non-invasive techniques.

Kalis B, De Rigal J, Léonard F, le Lévêque JL, De Riche O, Corre YL, Lacharriere OD.

Br J Dermatol. 1990 Jun;122(6):785-91.

PMID:
2369559

Supplemental Content

Support Center